Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2002
03/05/2002US6353109 Psychological disorders; sleep disorders; anticonvulsants; cognition activators
03/05/2002US6353107 1-alkoxy-polyallkyl-piperidine derivatives and their use as polymerization regulators
03/05/2002US6353105 Inhibitors of 5-hydroxy-tryptamine reuptake of a monoamine transporter; analogs of cocaine;
03/05/2002US6353099 Substituted ureas as cell adhesion inhibitors
03/05/2002US6353004 Peripherally acting anti-pruritic opiates
03/05/2002US6352996 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
03/05/2002US6352990 CRF receptor antagonists and methods relating thereto
03/05/2002US6352989 Nitrogenous heterocyclic derivatives and medicine thereof
03/05/2002CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity
03/05/2002CA2049850C 4-substituted dihydropyrido[4,3-d]pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
02/2002
02/28/2002WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
02/28/2002WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors
02/28/2002WO2002016340A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
02/28/2002WO2002016339A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
02/28/2002WO2001087887A3 Neuroprotective and anti-proliferative compounds
02/28/2002WO2001081343A3 Compounds for treating fibromyalgia and chronic fatigue syndrome
02/28/2002WO2001066545A3 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY
02/28/2002WO2001042216A3 Caspase inhibitors and uses thereof
02/28/2002WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/28/2002US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
02/28/2002US20020025967 Antiserotinone agents
02/28/2002US20020025962 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
02/28/2002US20020025960 Heterocycle carboxamides as antiviral agents
02/28/2002US20020025959 Heterocycle carboxamides as antiviral agents
02/28/2002US20020025956 Nervous system, psychological disorders
02/28/2002DE10040525A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases
02/28/2002DE10040016A1 Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-amyloid inhibitors, processes for their preparation and their use as medicaments
02/28/2002DE10039643A1 Funktionalisierte Perylentetracarbonsäurediimide Functionalized perylenetetracarbimides
02/28/2002CA2420024A1 Fused pyrazole derivatives being protein kinase inhibitors
02/28/2002CA2415852A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
02/28/2002CA2415182A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
02/28/2002CA2356058A1 Intermittent administration of a growth hormone secretagogue
02/27/2002EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders
02/27/2002EP1181933A2 Use of growth hormone secretagogues for stimulating or increasing appetite
02/27/2002EP1181335A1 Extended rhodamine compounds useful as fluorescent labels
02/27/2002EP1181293A1 Cucurbiturils and method for synthesis
02/27/2002EP1181282A2 Benzothiazinone and benzoxazinone compounds
02/27/2002EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
02/27/2002EP1181266A1 Squaric acid derivatives as cell adhesion molecules
02/27/2002EP0892789B1 Irreversible inhibitors of tyrosine kinases
02/27/2002EP0646180B1 Methods for inactivating nucleotide sequences and metal chelates for use therein
02/27/2002CN1337964A Novel aralkyl amines of spirofuropyridines useful in therapy
02/27/2002CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
02/27/2002CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases
02/26/2002US6350770 Microbiocides, insecticides
02/26/2002US6350760 Substituted piperidines as melanocortin-4 receptor agonists
02/26/2002US6350759 Dihydro- and tetrahydro-quinoline compounds
02/26/2002US6350757 Cns disorders; serotonergic activity on receptors of the 5-ht.sub.2 family.
02/26/2002US6350750 Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity
02/26/2002US6350748 Sulfamoyl compounds and agricultural and horticultural fungicides
02/26/2002US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents
02/26/2002CA2160966C Piperidine derivatives; process for preparing them and compositions containing the same
02/26/2002CA2093132C Process for the preparation of imidazo[4,5-c]quinolin-4-amines
02/26/2002CA2046801C Substituted pyrroles
02/21/2002WO2002014513A1 Use of polypeptide
02/21/2002WO2002014465A2 Multicyclic aromatic compounds and uses thereof
02/21/2002WO2002014414A2 Functionalized perylene tetracarboxylic acid diimides
02/21/2002WO2002014318A1 Liquid crystalline 3,4:9,10-perylenetetracarboxylic acid diimides
02/21/2002WO2002014317A2 Substituted pyrazoles
02/21/2002WO2002014316A1 Process for the preparation of imidazopyridines
02/21/2002WO2002014315A2 Substituted pyrazoles
02/21/2002WO2002014314A2 Substituted pyrazoles
02/21/2002WO2002014313A2 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
02/21/2002WO2002014311A2 Urea compounds and methods of uses
02/21/2002WO2002014306A1 Process for the preparation of imidazopyridines
02/21/2002WO2002014286A1 Preparation of risperidone
02/21/2002WO2002014271A1 Proline derivatives and use thereof as drugs
02/21/2002WO2002014269A2 2,4-substituted pyridine derivatives
02/21/2002WO2001089482A3 Method for preparing microparticles having a selected polymer molecular weight
02/21/2002WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
02/21/2002WO2001032631A3 Heterocyclic cytotoxic agents
02/21/2002WO2001019791A3 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments
02/21/2002US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests
02/21/2002US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
02/21/2002US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
02/21/2002US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration
02/21/2002US20020022624 Azaindole derivatives and their use as therapeutic agents
02/21/2002US20020022614 Thrombin or factor Xa inhibitors
02/21/2002DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands
02/21/2002DE10039232A1 Flüssigkristalline Perylen-3,4:9,10-tetracarbonsäurediimide Liquid crystalline perylene-3,4: 9,10-tetracarboxylic diimides
02/21/2002CA2549398A1 Preparation of risperidone
02/21/2002CA2549244A1 Preparation of risperidone
02/21/2002CA2419550A1 Substituted pyrazoles
02/21/2002CA2419540A1 Substituted pyrazoles
02/21/2002CA2418853A1 2,4-substituted pyridine derivatives
02/21/2002CA2418273A1 Urea compounds and methods of uses
02/21/2002CA2417821A1 Process for the preparation of imidazopyridines
02/20/2002EP1180514A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
02/20/2002EP1180105A2 Substituted aza-oxindole derivatives
02/20/2002EP1180030A1 Antibacterial compounds
02/20/2002EP1180028A1 Il-8 receptor antagonists
02/20/2002CN1336930A Bridged heterocyclic derivatives
02/20/2002CN1336916A Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
02/20/2002CN1336375A Spiro-and dicyclic diazine and carbozine oxazolidohne compound
02/20/2002CN1336374A Arylene compound, azomethine compound and silver halide photographic materials
02/20/2002CN1336356A Method for prepn. of alkaline organic nitrogen-contg. compound by using aluminium lithium oxide reduction method
02/19/2002US6348595 Perylene-3,4,9,10-tetracarboximide is hydroxymethylated by reaction with formaldehyde to form bis(hydroxymethyl) perylene-3,4,9,10-tetracarboximide; one pot process
02/19/2002US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists
02/19/2002US6348482 Catechols as antimicrobial agents
02/19/2002US6348474 Compounds as antidiabetic agents